Tag Archives: protection

MEPs call for the protection of fundamental values in the EU and worldwide | News | European Parliament

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Author: European Parliament
Read more here >>> The European Times News

Pfizer and Moderna Vaccines May Offer Lasting Protection, Study Finds

Prepped Pfizer and Moderna vaccines at a pharmacy in Little Rock, Ark., in March.
Credit…Rory Doyle for The New York Times

The vaccines made by Pfizer-BioNTech and Moderna set off a persistent immune reaction in the body that may protect against the coronavirus for years, scientists reported on Monday.

The findings add to growing evidence that most people immunized with the mRNA vaccines may not need boosters, so long as the virus and its variants do not evolve much beyond their current forms — which is not guaranteed. People who recovered from Covid-19 before being vaccinated may not need boosters even if the virus does make a significant transformation.

“It’s a good sign for how durable our immunity is from this vaccine,” said Ali Ellebedy, an immunologist at Washington University in St. Louis who led the study, which was published in the journal Nature.

The study did not consider the vaccine made by Johnson & Johnson, but Dr. Ellebedy said he expected the immune response to be less durable than that produced by mRNA vaccines.

Dr. Ellebedy and his colleagues reported last month that in people who had survived Covid-19, immune cells that recognize the virus remained in the bone marrow for at least eight months after infection. A study by another team indicated that so-called memory B cells continue to mature and strengthen for at least a year after infection.

Based on those findings, researchers suggested that immunity might last years, possibly a lifetime, in people who were infected and later vaccinated. But it was unclear whether vaccination alone might have a similarly long-lasting effect.

After an infection or a vaccination, a specialized structure called the germinal center forms in lymph nodes. This structure is an elite school of sorts for B cells.

The broader the range and the longer these cells have to practice, the more likely they are to be able to thwart variants of the virus that may emerge.

After infection with the coronavirus, the germinal center forms in the lungs. But after vaccination, the cells’ education takes place in lymph nodes in the armpits, within reach of researchers.

Dr. Ellebedy’s team found that 15 weeks after the first dose of vaccine, the germinal center was still highly active in all 14 of the participants, and that the number of memory cells that recognized the coronavirus had not declined.

“The fact that the reactions continued for almost four months after vaccination — that’s a very, very good sign,” Dr. Ellebedy said. Germinal centers typically peak one to two weeks after immunization, and then wane.

“Usually by four to six weeks, there’s not much left,” said Deepta Bhattacharya, an immunologist at the University of Arizona. But germinal centers stimulated by the mRNA vaccines are “still going, months into it, and not a lot of decline in most people.”

Dr. Bhattacharya noted that most of what scientists know about the persistence of germinal centers is based on animal research. The new study is the first to show what happens in people after vaccination.

The results suggest that a vast majority of vaccinated people will be protected over the long term — at least, against the existing variants. But older adults, people with weak immune systems and those who take drugs that suppress immunity may need boosters; people who survived Covid-19 and were later immunized may never need them at all.

Exactly how long the protection from mRNA vaccines will last is hard to predict. In the absence of variants that sidestep immunity, in theory immunity could last a lifetime, experts said. But the virus is clearly evolving.

Nurses preparing AstraZeneca vaccine doses in Bratislava, Slovakia, in April.
Credit…Akos Stiller for The New York Times

A third dose of the Covid-19 vaccine developed by AstraZeneca and the University of Oxford generated a strong immune response in clinical trial volunteers, Oxford researchers reported on Monday.

The finding indicates that the AstraZeneca vaccine could be an option should third shots end up being needed, for example, to extend immunity. To date, the vaccine has been given as two doses, typically between four and 12 weeks apart.

The new data, detailed in a preprint manuscript that has not yet been peer reviewed, came from 90 study volunteers in Britain who were among the earliest to receive the shots in a clinical trial last year. This past March, they were given a third dose, roughly 30 weeks after their second.

Laboratory analyses showed that the third dose increased levels of antibodies to the virus in the volunteers to a point higher than seen a month after their second dose — an encouraging sign that the third shot would be likely to bring greater protection if the effectiveness of two doses waned over time.

“We do have to be in a position where we could boost if it turned out that was necessary,” Prof. Andrew Pollard, an Oxford researcher who has led studies of the vaccine, said in a news conference on Monday. “I think we have encouraging data in this preprint to show that boosters could be used and would be effective at boosting the immune response.”

Scientists and policymakers do not yet know whether booster shots may be needed.

Scientists reported Monday that the vaccines made by Pfizer-BioNTech and Moderna set off a persistent immune reaction in the body that may protect against the coronavirus for years, but it isn’t clear if the same is happening with other vaccines, including AstraZeneca.

Emerging coronavirus variants could also accelerate the need for booster shots. If third shots are deemed necessary in the coming months, their availability could be severely limited, especially in poorer countries that are lacking enough supply to give first doses to their most vulnerable citizens.

Earlier this month, the National Institutes of Health announced that it has begun a new clinical trial of people fully vaccinated with any of the three authorized vaccines in the United States. The goal is test whether a booster shot of the vaccine made by Moderna will increase their antibodies against the virus. Initial results are expected later this summer.

The AstraZeneca vaccine has won authorization in 80 countries since last December but is not approved for use in the United States, which already has more than enough doses of its three authorized vaccines to meet demand. The shot has been the backbone of the struggling Covax program to provide vaccines to poor countries, accounting for more than 88 percent of the doses shipped out to middle- and low-income nations through last week.

AstraZeneca announced on Sunday that the first volunteers had been vaccinated in a separate study assessing a new version of the vaccine designed to protect against the Beta variant of the virus first seen in South Africa. Some study results suggested that the original version of the AstraZeneca vaccine may not be effective against that variant. Professor Pollard said the study would compare the effects of a third dose of the original vaccine against those of boosting volunteers with the new Beta-targeted vaccine.

Mounted police officers patrolling Bondi Beach in Sydney, Australia, on Monday.
Credit…Joel Carrett/EPA, via Shutterstock

Australia on Monday faced a grim and unfamiliar challenge: simultaneous outbreaks in several parts of the country — most notably in Sydney — fueled by the spread of the highly infectious Delta variant.

In the outbreak centered in Sydney, which has sent the city into at least a two-week lockdown, cases grew by 18 on Monday and now stand at 130. Other states across Australia also reported new cases and toughened restrictions, and an expansion of Australia’s lagging vaccination program was announced after an emergency cabinet meeting.

But even as anxiety about the outbreak intensified, many Australians found something to lighten the mood: a tale of two naked men caught violating lockdown rules in the woods of a national park, where they fled after a deer startled them out of their au naturel sunbathing on a secluded beach.

The stay-at-home orders introduced on Saturday allow for exercise. Fleeing wildlife nude did not qualify. The men, who were not identified, both received fines of 1,000 Australian dollars ($ 758). Mick Fuller, the police commissioner for New South Wales, which includes Sydney, was not pleased.

“It’s difficult to legislate against idiots,” Commissioner Fuller said at a news conference.

The news traveled quickly across the country to Western Australia, where the state premier, Mark McGowan, who recently closed his state’s borders to anyone from New South Wales, made clear that it was a Sydney thing.

“It wouldn’t happen here in W.A.,” he said. He added that he was worried about at least one of the suspects, saying: “I hope the deer’s OK.”

The two men were found by emergency responders, separately, at about 6 p.m. on Sunday, after one of them called for help, according to a police statement.

One of the men, 30, was found near a remote road in Royal National Park with simply a backpack. The other, 49, was partially clothed. They appeared to have violated the public health orders by leaving home for leisure.

And so, in a moment marked by rising anger at the government for failing to buy and distribute more vaccines, when Australia’s largest city stands to see its economy lose hundreds of millions of dollars from the lockdown, the news of a free-spirited buck-naked couple fleeing a buck — or was it a doe? — allowed for, well, something to smile about.

But there was worry, too, as tens of thousands of people in New South Wales rushed to get tested for the coronavirus, with more than 300 locations around Sydney having been identified as visited by people who were infectious.

That has raised concerns that the outbreak is far from over. Still, no deaths from the new outbreak have been recorded; no one in Australia has died from the virus at all this year. Two people are in intensive care, and officials encouraged everyone who is eligible for a vaccine to line up for one — and otherwise, stay home.

Global Roundup

Tourists enjoying the beach at the Spanish Balearic Island of Mallorca, Spain, this month.
Credit…Francisco Ubilla/Associated Press

Prime Minister Pedro Sánchez of Spain announced on Monday that British visitors would have to present a negative Covid-19 test or proof of full vaccination, bowing to concerns about a massive influx of summer tourists from Britain, which has been grappling with the Delta variant of the disease.

Last week, the British government added Spain’s Balearic Islands to its “green list” of countries and territories from which British visitors can return without quarantining, providing a major lift to the islands’ tourism-dependent economies.

But the authorities on the islands then asked Spain’s central government for tougher screening measures for arrivals from Britain. Sensitivities were also raised after an outbreak among hundreds of Spanish students who were visiting Mallorca, the largest of the islands, to celebrate the end of their academic year.

Spain lifted restrictions on British visitors on May 24, just as Germany, France and some other European countries reintroduced quarantine rules for the British in order to avoid the spread of the Delta variant. Since then, Germany and France have pushed for a British quarantine obligation to be applied across the European Union, but so far to no avail, as countries like Spain rely heavily on British visitors in the summer tourism season.

In other news from around the world:

  • Italy said on Monday that people were no longer required to wear masks outside, joining Spain and France in relaxing the rules as cases dropped. Masks must still be worn indoors and in crowded areas. In Rome, many still wore masks on Monday, citing concerns about the Delta variant, but some took advantage of the new rules. “It feels like freedom,” said Francesca Tronconi, a tour guide, as she crossed Piazza Navona with her mask around her arm.

  • Young people in Greece will be offered an incentive to get vaccinated, Prime Minister Kyriakos Mitsotakis said on Monday, in the form of a “freedom pass” with 150 euros, about $ 180, in prepaid credit to be spent on tourism, culture and travel. The pass will be available from July 15 for people ages 18 to 25 who have had at least one shot. “It is a thank you to youngsters for their patience and persistence and an incentive to get inoculated,” Mr. Mitsotakis said.

  • All passenger flights from Britain to Hong Kong will be banned starting Thursday to prevent the spread of the Delta variant, the city’s government said in a statement on Monday. The authorities have added Britain to an “extremely high-risk” list.

“This is not a get-out-of-jail-free card,” said Wendy Hechtman, who is serving a 15-year prison sentence but was released to home confinement during the pandemic. “But what it is is an opportunity card.”
Credit…Hilary Swift for The New York Times

Some 4,000 federal offenders who were part of a mass release last year of nonviolent prisoners to help slow the spread of the coronavirus could soon return to prison — not because they violated the terms of their home confinement, but because the United States appears to be moving past the worst of the pandemic.

In the final days of the Trump administration, the Justice Department issued a memo saying inmates whose sentences lasted beyond the “pandemic emergency period” would have to go back to prison.

But some lawmakers and activists are urging President Biden to revoke the rule and use his executive power to keep the prisoners on home confinement or commute their sentences entirely, arguing that the pandemic offers a glimpse into a different type of punitive system in America, one that would rely far less on incarceration.

Mr. Biden has vowed to make overhauling the criminal justice system a crucial part of his presidency, saying his administration could cut the prison population by more than half and expand programs that offered alternatives to detention.

While the White House has yet to announce a decision about those on home confinement, the administration appears to be following the direction of the Trump-era memo.

Andrew Bates, a spokesman for Mr. Biden, said in a statement that the president was “committed to reducing incarceration and helping people re-enter society,” but he referred questions about the future of those in home confinement to the Justice Department.

The White House revisits the emergency declaration every three months, leaving the former prisoners in a constant state of limbo. The next deadline is in July.

On the move in Dhaka, Bangladesh, on Monday as the government began to implement new lockdown measures.
Credit…Munir Uz Zaman/Agence France-Presse — Getty Images

Bangladesh will return to national lockdown by the end of the week, responding to a wave of infections that on Monday brought its highest single-day death toll of the pandemic so far.

The looming restrictions, imposed in a series of steps, have sent tens of thousands of migrant laborers in Dhaka, the capital and largest city, scrambling to get to their villages in scenes reminiscent of neighboring India’s migrant exodus last year.

The garment industry, which employs 4.5 million people and makes up 80 percent of the country’s exports, will remain open. But other businesses were instructed to limit their operations to minimum levels of required staffing, and almost all public transportation systems are either closing or already closed.

Residents of Dhaka expect to be largely confined to their homes after Thursday, the first day of what the government has called a “hard lockdown,” though how strictly the measures will be implemented remains to be seen. The government has said the army, police, and border guard will be deployed for strict enforcement.

Bangladesh had slowed the spread of the virus with sporadic restrictions and reduced movement while trying to keep much of the economy open. But a fast-spreading wave now, with barely 3 percent of the population vaccinated, has forced officials to take more drastic measures.

The country reported 119 deaths on Monday, the highest daily toll since the pandemic began, while the test positivity rate was over 20 percent. Bangladesh has officially reported a total of nearly 900,000 infections and 14,172 deaths from the virus, though experts believe the true numbers are much higher.

The current lockdown has been gradual. The government stopped trains and long distance buses last week. It also imposed lockdowns in seven districts surrounding Dhaka, aiming to avert a surge there. Shopping malls are closed, and restaurants are limited to takeout orders only.

The full lockdown, initially expected to last one week, begins on Thursday. All transportation systems except for auto-rickshaws will be shut.

The government has instructed garment factory owners to arrange transportation for their workers during previous rounds of restrictions. When the public transportation was shut in April to slow the spread of the virus, factory owners who did not arrange transportation were accused of violating the order, and workers had to walk for miles twice a day to get to work.

As the latest lockdown approached, ferry stations in Dhaka have been swamped by people trying to cross the river to the southern districts.

Dan Bourque, an Uber driver in San Francisco, saw Womply’s ads and applied for a loan in mid-April. Seventeen days later, he had a $  10,477 deposit in his bank account.
Credit…Jim Wilson/The New York Times

Though Congress approved billions in aid for small companies to help them keep paying their employees during the pandemic, it wasn’t reaching the tiniest and neediest businesses.

Then two small companies came out of nowhere and found a way to help those businesses.

They also helped themselves. For their work, the companies stand to collect more than $ 3 billion in fees, according to a New York Times analysis — far more than any of the 5,200 participating lenders.

One of the companies, Blueacorn, didn’t exist before the pandemic. The other, Womply, founded a decade ago, sold marketing software. But this year, they became the breakout stars of the Paycheck Protection Program.

Blueacorn and Womply aren’t banks, so they couldn’t actually lend any money. Rather, they acted as middlemen, charging into a gap between what big banks wouldn’t do and what small banks couldn’t do.

From late February to May 31, when the program ended, the companies processed 2.3 million loans. Most were for less than $ 17,000, and the vast majority went to solo ventures, which are more likely to be run by women and people of color.

All that hustle had downsides, however, including widespread customer service failures. And some lenders now have regrets about signing rushed deals that delivered most of the profit to their partners.

Gloria Molina, 28, checked in for her second dose of the vaccine at Samuel Rodgers Health Center in Kansas City, Mo.
Credit…Chase Castor for The New York Times

As the country’s vaccination campaign slows and doses go unused, it has suddenly become clear that one of the biggest challenges in reaching mass immunity will be persuading skeptical young adults of all backgrounds to get vaccinated.

Federal officials expressed alarm in recent days about low vaccination rates among Americans in their late teens and 20s, and have blamed them for the country’s all-but-certain failure to reach President Biden’s goal of giving 70 percent of adults at least an initial dose by July 4.

The straightforward sales pitch for older people — a vaccine could very possibly save your life — does not always work on healthy 20-somethings who know they are less likely to face the severest outcomes of Covid.

As public officials race to find ways to entice young adults to get vaccinated, interviews across the country suggest that no single fix is likely to sway these holdouts. Some are staunchly opposed. Others are merely uninterested. And still others are skeptical.

But pretty much everyone who was eager for a vaccine already has one, and public health officials now face an overlapping mix of inertia, fear, busy schedules and misinformation as they try to cajole Gen Z into getting a shot.

Public health experts say vaccinating young adults is essential to keeping infection numbers low and preventing new case outbreaks, especially as the more infectious Delta variant spreads.

Since vaccines became available six months ago, health departments have focused with varying degrees of success on urging groups identified as reluctant — including people living in rural communities, African American residents, conservatives — to get vaccinated.

But in recent days, public health officials have identified young adults as a significant challenge for a country where fewer than a million people a day are receiving a vaccine, down from an April peak of more than 3.3 million.

In a federal report released last week, just over one-third of adults ages 18 to 39 reported being vaccinated, with especially low rates among Black people; among people 24 or younger; and among those who had lower incomes, less education and no health insurance.

Author: The New York Times
This post originally appeared on NYT > Top Stories

Microbiome Therapeutic Offers Protection Against Recurrent C diff

SER-109, an oral microbiome therapeutic, safely protects against Clostridioides difficile recurrence for up to 24 weeks, according to a recent phase 3 trial. Three days of treatment with purified Firmicutes spores reduced risk of recurrence by 54%, suggesting a sustained, clinically meaningful response, according to a multicenter study presented at this year’s Digestive Disease Week® (DDW).

“Antibiotics targeted against C. difficile bacteria are necessary but insufficient to achieve a durable clinical response because they have no effect on C. difficile spores that germinate within a disrupted microbiome,” the investigators reported at the meeting.

“The manufacturing processes for SER-109 are designed to inactivate potential pathogens, while enriching for beneficial Firmicutes spores, which play a central role in inhibiting the cycle of C. difficile,” said Louis Y. Korman, MD, a gastroenterologist in Washington, who was lead author.

Extended Data From ECOSPOR-III

The ECOSPOR-III trial involved 182 patients with at least three episodes of C. difficile infection in the previous 12 months. Patients underwent 10-21 days of antibiotic therapy with fidaxomicin or vancomycin to resolve symptoms before they were then randomized in a 1:1 ratio to receive either SER-109 (four capsules daily for 3 days) or placebo, with stratification by specific antibiotic and patient age (threshold of 65 years).

The primary objectives were safety and efficacy at 8 weeks. These results, which were previously reported at ACG 2020, showed a 68% relative risk reduction in the SER-109 group, and favorable safety data. The findings presented at DDW added to those earlier ones by providing safety and efficacy data extending to week 24. At this time point, patients treated with SER-109 had a 54% relative risk reduction in C. difficile recurrence. Recurrence rates were 21.3% and 47.3% for the treatment and placebo groups, respectively (P less than .001).

Patients 65 years and older benefited the most from SER-109 therapy, based on a relative risk reduction of 56% (P less than .001), versus a 49% relative risk reduction (lacking statistical significance) for patients younger than 65 years (P = .093). The specific antibiotic therapy patients received also appeared to impact outcomes. Patients treated with fidaxomicin had a 73% relative risk reduction (P = .009), compared with 48% for vancomycin (P = .006). Safety profiles were similar between study arms.

“By enriching for Firmicutes spores, SER-109 achieves high efficacy, while mitigating risk of transmitting infectious agents and represents a major paradigm shift in the clinical management of patients with recurrent C. difficile infection,” the investigators concluded, noting that “an open-label study for patients with recurrent C. difficile infection is currently enrolling.”

Microbiome Restoration Therapies

Dr Sahil Khanna

According to Sahil Khanna, MBBS, professor of medicine at Mayo Clinic, Rochester, Minn., these findings “advance the field” because they show a sustained response. “We know that microbiome restoration therapies help restore colonization resistance,” Dr. Khanna said in an interview, noting that they offer benefits comparable to fecal microbiota transplantation (FMT) without the downsides.

“The trouble with FMT is that it’s heterogenous – everybody does it differently … and also it’s an invasive procedure,” Dr. Khanna said. He noted that FMT may transmit infectious agents between donors and patients, which isn’t an issue with purified products such as SER-109.

Several other standardized microbiota restoration products are under development, Dr. Khanna said, including an enema form (RBX2660) in phase 3 testing, and two other capsules (CP101 and VE303) in phase 2 trials. “The hope would be that one or more of these products would be approved for clinical use in the near future and would probably replace the vast majority of FMT [procedures] that we do clinically,” Dr. Khanna said. “That’s where the field is headed.”

The investigators reported no conflicts of interest. Dr. Khanna disclosed research support from Finch, Rebiotix/Ferring, Vedanta, and Seres.

This article originally appeared on MDedge.com, part of the Medscape Professional Network.

This post originally appeared on Medscape Medical News Headlines

Before Austin shooting, suspect’s family pleaded for more protection: “I’m afraid he might hurt me”

Author: Reis Thebault and Brittany Shammas, The Washington Post
This post originally appeared on The Texas Tribune: Main Feed

Pfizer vaccine efficacy: What protection does Pfizer vaccine give after second dose?

In late February, Public Health England also published an independent analysis which showed the Pfizer/BioNTech vaccine is effective against COVID-19 from the first dose.

The Government website explained: “Early data from PHE’s SIREN study shows a promising impact on infection in healthcare workers aged under 65.

“Healthcare workers in the study are tested for coronavirus (COVID-19) every 2 weeks – whether or not they have symptoms.

“Data shows one dose reduces the risk of catching infection by more than 70 percent, rising to 85 percent after the second dose.”

Although results are promising, people who have had a vaccine are still advised they could still get or spread coronavirus.

People must still follow social distancing guidance and the rules on face coverings after being vaccinated.

Read More

Texas renters face eviction as state protection lapses

Texans behind on their rent are at increasing risk of losing their homes despite a federal moratorium on evictions, according to housing attorneys, because a Texas Supreme Court order aimed at forestalling evictions has expired.

The nationwide order from the Centers for Disease Control and Prevention halting evictions through June 30 — originally issued under the Trump administration[2] — has been an important bulwark against a housing crisis as people lost jobs and income during the pandemic, housing advocates say.

But an emergency order[3] issued by the Texas Supreme Court that instructed judges across Texas how to follow the federal mandate expired March 31.

Without the explicit backup of the moratorium from the state’s highest civil court, Texas landlords could resume pursuing evictions of people affected by the pandemic, housing advocates said, and it could fall to the federal government to enforce the CDC order.

“A lot of people have been saying for the last year that this eviction wave is coming and that we are about to step off this cliff into the abyss. With this latest news, we just stepped off that cliff. This is the worst case scenario,” said Mark Melton, an attorney who has helped hundreds of Dallas-area tenants during the pandemic. “This basically says that if a landlord wants to risk federal prosecution, that’s their business, not our problem. And if they want the eviction we have to grant it under state law.”

The Texas Justice Court Training Center, which trains judges and issues procedural guidance, has updated its eviction-related guidelines[4] to say that Texas courts can proceed with eviction cases, although “the landlord might choose to place this case on hold.”

“This just means that the courts in Texas would follow Texas procedure in law, which doesn’t have anything in it about the CDC moratorium. Now there could be local laws that would maybe have a moratorium,” said Theadora Wallen, the training center’s executive director.

To be protected by the CDC order, renters must sign a declaration[5] stating they risk homelessness due to effects of the pandemic, among other requirements. The CDC order subjects violators to fines up to $ 100,000 and a year in jail. The penalties are steeper if violating the order results in death. Until March 31, justices of the peace in Texas played a key role enforcing it, halting eviction proceedings they believed violated the CDC order. Now it will be up to individual judges to decide whether to follow the federal orders.

Meanwhile, a Texas program meant to financially help renters who have fallen behind has barely taken root.

“In essence, the Texas Supreme Court and the state’s leaders are abdicating their powers and moral obligation to protect renters from homelessness. Meanwhile, the $ 1.3 billion state-run rental assistance program has stumbled. As of less than two weeks ago, fewer than 130 payments had been made,” said Christina Rosales, deputy director of the advocacy group Texas Housers, in a statement. “Program administrators, who had aimed to process applications within 14 days, say that 60 days is closer to average. If landlords are able to evict tenants who have applied for rent relief, the program will fail before it has had the chance to succeed.”

According to Kristina Tirloni, spokesperson for the Texas Department of Housing and Community Affairs, as of April 2 the program had provided $ 2.3 million in rent relief for 358 households. But when TDHCA announced the program in February[6] — tapping federal funds — the agency said it hoped to help around 80,000 households.

“Texas received more than $ 1 billion to start this first-time statewide rent program from scratch, with little to no federal guidance,” Tirloni said. “The system will ramp up considerably in the coming days and weeks, and we are preparing to administer another round of funding, approximately $ 1 billion more, very soon.”

The slow deployment of assistance hasn’t been a problem just in Texas. The Texas Tribune reached out to agencies in the six biggest states, and all have experienced similar delays. Some, like Florida, have not even opened the application process.

For Texans who have lost income, the delays are feeding stress and uncertainty. According to a survey by the U.S. Census Bureau[7] released in March, around 1.5 million households in Texas have slight or no confidence in their ability to pay next month’s rent. The problem is most common among Black and Hispanic households. That’s the case for Nini Maldonado, a mother of five in Katy, who has applied to city and state rent relief programs with no success.

“We would call the customer service hotline and no one would pick up,” Maldonado said in Spanish. “We would be waiting for an hour and then the call would drop. We never managed to get help to fill up the forms.”

Maldonado works in a restaurant, and her husband is in construction. During the last year, both lost hours of work and sometimes were unemployed. On top of that, the couple contracted COVID-19, leaving them out of work in December. Right now, she owes two and a half months’ rent, and although their landlord is open to a payment plan, he has also said he is ready to proceed with their eviction.

“He told us that if by April 3 we haven’t paid rent plus $ 200 [of the amount owed], he is going to court,” Maldonado said. “My husband is a calm person, he tries to stay positive. But I do feel this very hard on myself, I think about where we will go with the five kids if they throw us out.”

Landlords — many also struggling to pay for mortgages and maintenance — also complain about the slow and cumbersome access to rent relief. David Mintz, vice president of government affairs at the Texas Apartment Association, said rent relief is key, and he expects the program to speed up.

“While the Texas Apartment Association opposes the CDC order, so long as it remains in effect we will continue to educate rental property owners about complying with its provisions,” Mintz said. “The real focus needs to be on ensuring the Texas Rent Relief Program, the Texas Eviction Diversion Program and similar programs in local communities are running efficiently.”

Nelson Mock, a housing attorney for Texas RioGrande Legal Aid, said that the organization’s immediate concern is eviction cases that were already in the legal pipeline before they were halted, when the judge had already instructed a constable to proceed with the eviction.

“If a tenant is at the end of the process, where the judgment is final and a writ is allowed, then the tenant is given 24-hour notice and removed,” said Mock, who has heard of many evictions that were stopped at the last minute. “Once that pause is lifted, once that abatement is lifted, they will get this almost immediate removal from their homes.”

Given the lack of protection for tenants in the state’s new guidelines, having legal advice could be key for people risking eviction, but in Texas most of them appear in courts on their own. Many avoid court altogether. Mock said that many attorneys and advocates are asking the Texas Justice Court Training Center to change its recommendations and, in the meantime, are advising tenants to be proactive and seek legal aid[8].

“Anyone who has the protections of the CDC order should be urging the courts to follow the CDC order,” Mock said. “To the extent that they have a landlord who is not following the order, there is a help line, a complaint line[9] that the [Consumer Financial Protection Bureau] has set up. Tenants should be reporting these problems.”

Disclosure: The Texas Apartment Association has been a financial supporter of The Texas Tribune, a nonprofit, nonpartisan news organization that is funded in part by donations from members, foundations and corporate sponsors. Financial supporters play no role in the Tribune’s journalism. Find a complete list of them here[10].


  1. ^ Sign up for The Brief (www.texastribune.org)
  2. ^ originally issued under the Trump administration (www.texastribune.org)
  3. ^ emergency order (www.txcourts.gov)
  4. ^ has updated its eviction-related guidelines (www.tjctc.org)
  5. ^ sign a declaration (www.cdc.gov)
  6. ^ when TDHCA announced the program in February (www.texastribune.org)
  7. ^ According to a survey by the U.S. Census Bureau (www.census.gov)
  8. ^ seek legal aid (texaslawhelp.org)
  9. ^ a complaint line (www.consumerfinance.gov)
  10. ^ list of them here (www.texastribune.org)

Juan Pablo Garnham